Delivery Order SPE2DB20D3101-SPE2DB25FRRL6
Award Date 7/30/25
Potential Completion Date 8/20/25
Potential Value $3.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $3,106.80 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENVARSUS XR 1 MG TABLET 30S, a prescription medication, to support federal medical procurement needs, particularly for military and veteran healthcare systems. The contract is not set-aside and is associated with a larger $999,999,999.00 Indefinite...
- This is a $1,169.76 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of ENVARSUS XR 0.75 MG TABLET 30S, a pharmaceutical product. The delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical, which serves as a vehicle for...
- The Department of Defense's Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order contract to AmerisourceBergen Drug Corp in the amount of $1,615.33 for the supply of ENVARSUS XR 4 MG TABLET 100S. The contract has an ultimate completion date of October 10, 2024. AmerisourceBergen, a major pharmaceutical distributor, is supplying this critical medication under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Envarsus XR 1 mg tablets (30-count supply) valued at $3,106.80, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Envarsus XR is an extended-release formulation of tacrolimus, an immunosuppressant medication commonly used in...
- This is a $1,711.95 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ENVARSUS XR 4 MG TABLET 100S, a transplant medication, to support military healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,339.52, is for the supply of ENVARSUS XR 0.75 MG TABLET 30S, a medication used in transplant patient care. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued...
- This federal contract award, with a ceiling value of $3,423.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENVARSUS XR 4 MG TABLET 100S, a pharmaceutical product, with an ultimate completion date of April 11, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for $1,615.33 to supply ENVARSUS XR 4 MG TABLET 100S. This order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide ENVARSUS XR 4 MG TABLET 100S, a specialty pharmaceutical product, with a ceiling value of $3,230.68. The contract has an ultimate completion date of April 15, 2024. This award is part of a larger indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, valued up to $999,999,999.00 through...
- This is a $1,718.48 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ENVARSUS XR 1 MG TABLET 100S, a pharmaceutical product, with a period of performance through May 5, 2025. The award is not associated with a set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary...